全肩关节置换术与半肩关节置换术的经济学评价
该研究从加拿大公共资助医疗体系视角,采用Markov模型进行成本-效用分析,比较全肩关节置换术(TSA)与半肩关节置换术(HA)在全生命周期内的成本和质量调整生命年(QALYs)。结果显示TSA成本更低且效果更好,在每获得1个QALY支付意愿50000美元的阈值下具有成本效果。
要点
- TSA在全生命周期内成本低于HA且QALYs更高,属于优势策略。
- 在50000美元/QALY的支付意愿阈值下,HA不具有成本效果。
- TSA具有成本效果的概率为100%,包括年龄≤50岁的患者。
核心结论
- 从加拿大公共资助医疗体系视角,在每获得1个QALY支付意愿50000美元的阈值下,TSA相比HA在所有患者中均具有成本效果,包括年龄≤50岁者。
研究设计与样本
- 采用Markov模型进行成本-效用分析,模拟TSA或HA患者在全生命周期内的成本和QALYs,并按年龄组(≤50岁或>50岁)进行亚组分析,结果以2019年美元呈现。
主要发现
- TSA在全生命周期内成本为115785美元,低于HA的118501美元;TSA获得10.21个QALYs,高于HA的8.47个QALYs,TSA为优势策略。
- TSA和HA后健康效用值的变化对成本效果结果影响最大。
- 在每获得1个QALY支付意愿50000美元的阈值下,HA不具有成本效果;TSA具有成本效果的概率为100%。
关键数值与推荐
- 支付意愿阈值为每获得1个QALY50000美元。
- TSA成本115785美元,HA成本118501美元;TSA获得10.21个QALYs,HA获得8.47个QALYs。
- 证据等级为Economic and Decision Analysis Level II。
临床怎么用
- 在公共资助医疗体系中,优先选择TSA而非HA可能更具经济性,包括对年龄≤50岁的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although outcome studies generally demonstrate the superiority of a total shoulder arthroplasty (TSA) over a hemiarthroplasty (HA), comparative cost-effectiveness has not been well studied. From a publicly funded health-care system's perspective, this study compared the costs and quality-adjusted life-years (QALYs) in patients who underwent TSA with those in patients who underwent HA. METHODS: We conducted a cost-utility analysis using a Markov model to simulate the costs and QALYs for patients undergoing either TSA or HA over a lifetime horizon to account for costs and medically important events over the patient lifetime. Subgroup analyses by age groups (≤50 or >50 years) were performed. A series of sensitivity analyses were performed to assess robustness of study findings. The results were presented in 2019 U.S. dollars. RESULTS: TSA was dominant as it was less costly ($115,785 compared with $118,501) and more effective (10.21 compared with 8.47 QALYs) than HA over a lifetime horizon. Changes to health utility values after TSA and HA had the largest impact on the cost-effectiveness findings. At a willingness-to-pay (WTP) threshold of $50,000 per QALY gained, HA was not found to be cost-effective. The probability that TSA was cost-effective was 100%. CONCLUSIONS: Based on a WTP of $50,000 per QALY gained, from the perspective of Canada's publicly funded health-care system, TSA was found to be cost-effective in all patients, including those ≤50 years of age, compared with HA. LEVEL OF EVIDENCE: Economic and Decision Analysis Level II. See Instructions for Authors for a complete description of levels of evidence.
引用
- Lapner P, Kumar S, van Katwyk S, et al. Total Shoulder Arthroplasty Is Cost-Effective Compared with Hemiarthroplasty: A Real-World Economic Evaluation. J Bone Joint Surg Am. 2021. PMID: 33886522. doi:10.2106/JBJS.20.00678
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。